The Religare-Milestone Capital joint venture for private equity funding is all set to make its first investment within a month…
Counterfeit pharmaceutical products are a global problem originating not just in developing countries like India but also developed countries like…
The recent US FDA decision to issue an emergency use authorisation for Tamiflu as a drug for the swine flu…
The patent dispute over bird flu drug Tamiflu does not seem to settle down. Gilead Sciences, the manufacturer of the…
With the uncertainty in the private equity sector due to the diminishing valuations and the exit time fast approaching, major…
Zydus Pharma Inc, the US subsidiary of the Ahmedabad-based pharma major Zydus Cadila, has been sued by US major Wyeth,…
Diminishing stock prices in a gloomy market has made life tough for major PE players, who had made large investments…
As if the travel and tour operators besides advertisements singing paeans to the African safari is not enough, when one…
The plight of the private equity industry in the country continues, despite claims that it is bouncing back slowly. PE…
Reliance Big Pictures, the movie production arm of Anil Ambani-owned Reliance Entertainment, is set to take all of its art-house…
The diversified Hinduja Group is learnt to have opened talks with Wockhardt Ltd to acquire a majority stake in its…
Caraco Pharmaceuticals, the US-based subsidiary of Sun Pharma, has come under USFDA scanner, prompting it to voluntarily recall from the…
After years of waiting, Indian biotech companies can launch their generic biotech drugs in the US when it opens up…
Private equity investments in India are slowing down. PE funds invested $291 million in 18 deals in February 2009 compared…
Private equity investors are tightening their grip over promoters by falling back on protective provisions in definitive agreements, as terms…
Axis Private Equity, the private equity arm of Axis Bank, is set to close its latest investment in a South…
Industry experts and investment bankers feel that there is a possibility that Piramal Life Sciences Ltd, Piramal?s R&D entity, may…
Fund managers in India can breathe a sigh of relief, despite the fact that the days ahead for private equity…
